Deleterious effects of selective serotonin reuptake inhibitor treatment on semen parameters in patients with lifelong premature ejaculation
International Journal of Impotence Research: The Journal of Sexual Medicine, Exclusive Author Commentary

Koyuncu H et al. – Although no drug for premature ejaculation (PE) has been approved by regulatory bodies, chronic selective serotonin reuptake inhibitors proved to be effective in treating lifelong PE. Despite the rising use and known effects of antidepressants on ejaculation, only a few reports have evaluated the impact of these drugs on the male fertility.

Following View Author Commentary page

Premature ejaculation (PE), the most common sexual dysfunctions in men and is characterized by the loss or absence of ejaculatory control. The prevalence rate of PE has been reported to be between 21% to 31% and is recognized to impact on a man’s life in many ways, such as reducing self-esteem, affecting interpersonal relationships, causing anxiety, embarrassment, depression and reducing overall quality of life. Recent guidelines have proposed chronic use of SSRIs (e.g. fluoxetine, sertraline, paroxetine and citalopram) for the treatment of lifelong PE. The SSRIs block 5-hydroxytriptamine (5-HT) transporter mechanisms and thereby increase 5-HT within the synapses. This in turn activates 5-HT1A and 5-HT1B receptors resulting in inhibition of serotonin release into the synapse. With chronic administration of SSRIs, the receptors become desensitized and there is a reduction of inhibitory action on serotonin release. The end result is more serotonin release into the synapse, of the ejaculatory set point, and delay in the ejaculatory reflex. In spite of their efficacy, adverse effects are the major drawback in chronic use of SSRIs in PE patients. Well known adverse effects of SSRIs include sexual dysfunction (sexual desire and arousal difficulties, anejaculation, absent and delayed orgasm), dizziness, nausea, constipation, insomnia and fatigue. Few studies have addressed the impact of SSRIs on spermatozoal function and fertility. Published data clearly show that chronic SSRI treatment has a detrimental effect on spermatogenesis and sperm transport, damages the sperm membrane, alters sperm DNA and has an impact on hormonal homeostasis. These effects may not be important for men undergoing treatments for severe depression; however they must be taken into consideration when SSRIs are administered to a sexually active man with PE. In summary, the potential advers effects of SSRIs on male fertility needs to be considered when treating a young man with PE.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Urology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Urology Articles

1 Hormone and radiotherapy versus hormone or radiotherapy alone for non-metastatic prostate cancer: A systematic review with meta-analyses Clinical Oncology, August 8, 2014    Evidence Based Medicine    Review Article

2 Enclomiphene citrate stimulates testosterone production while preventing oligospermia: A randomized phase II clinical trial comparing topical testosterone Fertility and Sterility, July 25, 2014    Clinical Article

3 Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients Urologic Oncology: Seminars and Original Investigations, August 20, 2014    Clinical Article

4 Incidence of needle tract seeding following prostate biopsy for suspected cancer - Review of the literature BJU International, June 30, 2014    Review Article

5 Sexually transmitted infections and prostate cancer risk: A systematic review and meta-analysis Cancer Epidemiology, August 1, 2014    Evidence Based Medicine    Review Article

6 Impact of family history on prostate cancer mortality in Caucasian men undergoing PSA-based screening The Journal of Urology, August 4, 2014    Clinical Article

7 Association of androgen deprivation therapy with excess cardiac-specific mortality in men with prostate cancer BJU International, August 19, 2014    Clinical Article

8 Association of body mass index and prostate cancer mortality Obesity Research & Clinical Practice, July 24, 2014    Clinical Article

9 Extraprostatic extension of prostatic carcinoma: Is its proximity to surgical margin or gleason score important? BJU International, August 22, 2014    Clinical Article

10 Anxiety in the management of localised prostate cancer by active surveillance BJU International, August 13, 2014    Clinical Article

11 PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer International Journal of Urology, August 6, 2014    Clinical Article

12 Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancer Urologic Oncology: Seminars and Original Investigations, August 26, 2014    Clinical Article

13 Combination of lidocaine suppository and periprostatic nerve block during transrectal prostate biopsy: A prospective randomized trial International Journal of Urology, July 2, 2014    Clinical Article

14 Smoking and risk of low- and high-grade prostate cancer: Results from the REDUCE study Clinical Cancer Research, August 27, 2014    Clinical Article

15 Prostate cancer risk assessment tools in an unscreened population World Journal of Urology, August 7, 2014    Clinical Article

16 Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone The Prostate, August 14, 2014    Clinical Article

17 Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology The Lancet Oncology, July 30, 2014    Clinical Article

18 Radiation-induced secondary malignancy in prostate cancer: A systematic review and meta-analysis Urologia Internationalis, August 19, 2014    Evidence Based Medicine    Review Article

19 Urinating standing versus sitting: Position is of influence in men with prostate enlargement. A systematic review and meta-analysis PLOS ONE, August 1, 2014    Evidence Based Medicine    Review Article
Exclusive Author Commentary

20 Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy Journal of Magnetic Resonance Imaging, July 1, 2014    Clinical Article

Indexed Journals in Urology: Urology, Journal of Urology, European Urology, The Prostatemore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close